Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2021 PRIZE WINNERS

2021 Prize Winners

News

October 4, 2021
PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2022 Prize for Early-Career, Radically Innovative Cancer Researchers

THE PERSHING SQUARE FOUNDATION/ BUSINESS WIRE – The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2022 Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for three years is awarded annually to at least six New York City area-based scientists. The prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.

“With cancer genomics and single-cell technologies becoming a reality, along with advances in immunotherapy, metabolic targets and next-generation sequencing data, the pursuit of basic science alongside applied engineering has never been so opportune. Novel treatment strategies will in this way yield biological discoveries, and vice versa. We are proud to support early-career scientists driven by research which has the potential to activate state-of-the-art clinical treatment while revealing new scientific insights,” said Pershing Square Foundation Trustee Neri Oxman. “We look forward to reviewing the applications as we continue to grow our PSSCRA community.”

READ MORE

Events

October 24, 2019 
2019 PRIX GALIEN PRESIDENT’S DINNER, ANNUAL GALIEN FORUM, AND ANNUAL PRIX GALIEN USA AWARDS CEREMONY

The Prix Galien recognizes outstanding innovation to improve the human condition by means of biomedical research.  It is considered the industry’s equivalent of the Nobel Prize, the highest accolade for biomedical research and development.  The annual Galien Forum is a meeting-of-the minds at which pressing issues are debated by front-runners in industry, academia and government. This is a special opportunity for recipients of the Pershing Square Sohn Prize for Young Investigators in Cancer Research to spend time with such leaders.

Pershing Square Sohn Prize winners, Scientific Review Council members, and guests which included individuals from philanthropy, academia, industry, and business attended this year’s Forum at the Alexandria Center for Life Science in New York City. The event featured talks by executives from the pharmaceutical, biotechnology, and medical industries, as well as top academics and government representatives.  Following the Forum, select guests were invited to attend the Prix Galien Awards Ceremony at the American Museum of Natural History.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation